Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 125 of 272 entries
View as:

A Study to Document and to Further Describe Long-term Safety and Effectiveness of Palovarotene in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Phase: N/A Priority: Normal
NCT ID: NCT06089616 Org: User:
Start: 12/05/24 End: 01/31/34 Due: 01/31/35

Study of Cabozantinib as 2nd Line Treatment in Subjects With Locally Advanced or Metastatic Renal Cell Carcinoma (RCC) With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT03945773 Org: User:
Start: 01/08/20 End: 12/30/30 Due: 12/30/31

CARegiver BURden, Effectiveness and Other Health Care Measures on Functional Disability, in Patients Treated With Abobotulinumtoxin A for Upper Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT06245772 Org: User:
Start: 11/16/23 End: 09/30/26 Due: 09/30/27

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT06047444 Org: User:
Start: 10/12/23 End: 12/21/26 Due: 12/21/27

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT06047457 Org: User:
Start: 09/29/23 End: 12/21/26 Due: 12/21/27

A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.

Phase: N/A Priority: Normal
NCT ID: NCT04936542 Org: User:
Start: 06/23/21 End: 10/31/25 Due: 10/31/26

A Study to Estimate How Often Post-stroke Spasticity Occurs and to Provide a Standard Guideline on the Best Way to Monitor Its Development

Phase: N/A Priority: Normal
NCT ID: NCT06055725 Org: User:
Start: 11/01/23 End: 11/30/27 Due: 11/30/28

A Study to Assess a New Medicine Called IPN01195 When Administered Alone in Adults With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT06833008 Org: User:
Start: 03/14/25 End: 10/03/28 Due: 10/03/29

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

Phase: N/A Priority: Normal
NCT ID: NCT05027802 Org: User:
Start: 03/14/22 End: 11/30/24 Due: 11/30/25

Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation

Phase: N/A Priority: Normal
NCT ID: NCT06258902 Org: User:
Start: 09/28/23 End: 09/02/32 Due: 09/02/33

Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With Osteosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT06341712 Org: User:
Start: 11/22/24 End: 06/15/28 Due: 06/15/29

A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid.

Phase: N/A Priority: Normal
NCT ID: NCT06383403 Org: User:
Start: 07/09/24 End: 10/31/26 Due: 10/31/27

Study to Assess the Safety and Efficacy of Intravenous Injection of the Imaging Agent 111In-IPN01087 in Patients With Locally Advanced or Metastatic Pancreatic or Colorectal Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT04632199 Org: User:
Start: 03/12/21 End: 12/10/21 Due: 12/10/22

A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT06305247 Org: User:
Start: 04/03/24 End: 03/20/28 Due: 03/20/29

A Study of Elafibranor in Adult Japanese Participants With Primary Biliary Cholangitis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT06730061 Org: User:
Start: 01/16/25 End: 04/08/32 Due: 04/08/33

A Study of the Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

Phase: N/A Priority: Normal
NCT ID: NCT06908954 Org: User:
Start: 03/14/25 End: 06/17/26 Due: 06/17/27

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Phase: N/A Priority: Normal
NCT ID: NCT04526665 Org: User:
Start: 09/24/20 End: 12/01/28 Due: 12/01/29

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Phase: N/A Priority: Normal
NCT ID: NCT06625060 Org: User:
Start: 10/10/24 End: 06/15/27 Due: 06/15/28

Study to Evaluate a Subcutaneous Four Months Sustained-release Formulation of Triptorelin in Patients With Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00415246 Org: User:
Start: 11/30/06 End: 10/31/07 Due: 10/31/08

Study to Assess the Non-inferiority of Pamorelin® 11,25mg SC Injected Versus Pamorelin® 11,25mg IM Injected in Patients Suffering From Advanced Prostate Cancer (PAMOJECT)

Phase: N/A Priority: Normal
NCT ID: NCT00444639 Org: User:
Start: 02/28/07 End: 06/30/08 Due: 06/30/09

Dysport in Vulvodynia Phase II Study

Phase: N/A Priority: Normal
NCT ID: NCT03598777 Org: User:
Start: 06/11/18 End: 01/21/21 Due: 01/21/22

DYSPORT™ Clinical & Health Economics Outcomes Registry in Cervical Dystonia

Phase: N/A Priority: Normal
NCT ID: NCT01314365 Org: User:
Start: 04/30/11 End: 03/31/14 Due: 03/31/15

RELIEF Study: Lower Limb Pain Relief After Injection Cycles in Adults Suffering From Lower Limb Spasticity Following Stroke

Phase: N/A Priority: Normal
NCT ID: NCT02020980 Org: User:
Start: 04/30/14 End: 03/05/18 Due: 03/05/19

Dysport® Adult Lower Limb Spasticity Study

Phase: N/A Priority: Normal
NCT ID: NCT01249404 Org: User:
Start: 03/31/11 End: 05/31/14 Due: 05/31/15

Study of Diphereline 3.75 mg Treatment In Women Suffering From Internal Genital Endometriosis

Phase: N/A Priority: Normal
NCT ID: NCT03586063 Org: User:
Start: 11/03/11 End: 12/24/14 Due: 12/24/15